Angiogenesis Inducing Agents
"Angiogenesis Inducing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that induce or stimulate PHYSIOLOGIC ANGIOGENESIS or PATHOLOGIC ANGIOGENESIS.
Descriptor ID |
D043925
|
MeSH Number(s) |
D27.505.696.377.077.077
|
Concept/Terms |
Angiogenesis Inducing Agents- Angiogenesis Inducing Agents
- Agents, Angiogenesis Inducing
- Inducing Agents, Angiogenesis
- Angiogenesis Stimulating Agents
- Agents, Angiogenesis Stimulating
- Stimulating Agents, Angiogenesis
- Angiogenesis Stimulators
- Stimulators, Angiogenesis
- Angiogenesis Inducers
- Inducers, Angiogenesis
Angiogenesis Effect- Angiogenesis Effect
- Effect, Angiogenesis
- Angiogenesis Effects
- Effects, Angiogenesis
|
Below are MeSH descriptors whose meaning is more general than "Angiogenesis Inducing Agents".
Below are MeSH descriptors whose meaning is more specific than "Angiogenesis Inducing Agents".
This graph shows the total number of publications written about "Angiogenesis Inducing Agents" by people in this website by year, and whether "Angiogenesis Inducing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Angiogenesis Inducing Agents" by people in Profiles.
-
Johnson KM, Smith L, Modest AM, Salahuddin S, Karumanchi SA, Rana S, Young BC. Angiogenic factors and prediction for ischemic placental disease in future pregnancies. Pregnancy Hypertens. 2021 Aug; 25:12-17.
-
Johnson KM, Specht AJ, Hart JM, Salahuddin S, Erlinger AL, Hacker MR, Woolf AD, Hauptman M, Karumanchi SA, Wylie BJ, O'Brien K. Lead exposure and association with angiogenic factors and hypertensive disorders of pregnancy. Pregnancy Hypertens. 2020 Oct; 22:93-98.
-
Shao R, Taylor SL, Oh DS, Schwartz LM. Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization. Oncotarget. 2015 Dec 01; 6(38):40507-18.
-
Maynard SE, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Moore Simas TA. Gestational angiogenic biomarker patterns in high risk preeclampsia groups. Am J Obstet Gynecol. 2013 Jul; 209(1):53.e1-9.
-
Yan W, Bentley B, Shao R. Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis. Mol Biol Cell. 2008 May; 19(5):2278-88.
-
Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol. 2007 Sep; 197(3):244.e1-8.
-
Gravallese EM, Pettit AR, Lee R, Madore R, Manning C, Tsay A, Gaspar J, Goldring MB, Goldring SR, Oettgen P. Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha. Ann Rheum Dis. 2003 Feb; 62(2):100-7.
-
Spodick DH. Microphysiology of the pericardium in relation to intrapericardial therapeutics and diagnostics. Clin Cardiol. 1999 Jan; 22(1 Suppl 1):I2-3.